QN-023a
IIT2022029
Phase 1 small_molecule terminated
Quick answer
QN-023a for AML, Adult is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- AML, Adult
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated